Merck KGaA Acquires Microbiology Business Of Biotest AG
22 Marzo 2011 - 4:12AM
Noticias Dow Jones
Germany's Merck KGaA (MRK.XE) said Tuesday it has entered into a
definitive agreement to acquire the microbiology business of
Biotest AG (BIO.XE), Germany.
MAIN FACTS:
-The business has approximately 290 employees and generated
sales of approximately EUR50 million in 2010.
-This business comprises heipha Dr. Muller GmbH, located in
Eppelheim, Germany, as well as the Hycon business located in
Dreieich, the subsidiaries in France, Japan and in the USA as well
as further activities and employees in several European
countries.
-The agreement is subject to antitrust approvals in Germany and
Austria.
-Closing of the transaction is expected in the second half of
2011.
-Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500
Biotest (PK) (USOTC:BTTAY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Biotest (PK) (USOTC:BTTAY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Biotest AG (PK) (OTCMarkets): 0 recent articles
Más de Biotest AG ADS Artículos de Noticias